PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. Electronic address: hburstein@partners.org.\', \'European Institute of Oncology, University of Milan, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.\', \'Cantonal Hospital, St. Gallen, Switzerland.\', \'University of Basel, Basel, Switzerland.\', \'University of Antwerp, Antwerp, Belgium.\', \'Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.\', \'St. Gallen Oncology Conferences (Foundation SONK), St. Gallen, Switzerland.\', \'Medical University of Vienna, Vienna, Austria.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0923-7534(21)02104-910.1016/j.annonc.2021.06.023
?:doi
?:hasPublicationType
?:journal
  • Annals of oncology : official journal of the European Society for Medical Oncology
is ?:pmid of
?:pmid
?:pmid
  • 34242744
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all